Relationship Between Compliance with Oral Hypoglycemic Drugs and Hs-CRP Levels in Type 2 Diabetes Mellitus
DOI:
10.29303/jbt.v25i3.9201Published:
2025-07-30Downloads
Abstract
Type 2 diabetes mellitus is a chronic condition with hyperglycemia due to insulin resistance and impaired insulin secretion, where oral medication non-compliance can worse glycemic control and trigger inflammation characterized by elevated hs-CRP levels. This research aims to examine the relationship between compliance with oral hypoglycemic drugs and hs-CRP levels in patients with diabetes mellitus. This study used a cross-sectional design with purposive sampling of 20 patients with type 2 diabetes mellitus at Puskesmas Mojolaban. Compliance was assessed by MARS-10 and hs-CRP levels were measured by immunoturbidimetry, then analyzed by descriptive statistics and correlation with Fisher’s Exact Test. The results showed that 95% of respondents who adhered to their medication had normal hs-CRP levels (<0.85 mg/L), while 5% of non-adherent respondents had abnormal hs-CRP levels (>0,85 mg/L). The Fisher’s Exact Test result in a p-value = 0.050, indicating a significant relationship between compliance with oral hypoglycemic drugs and hs-CRP levels. Compliance to oral medication in patients with type 2 diabetes mellitus may be an effective strategy to suppress systemic inflammation (hs-CRP) and prevent macrovascular compliactions.
Keywords:
Compliance; Oral Hypoglycemic Drugs; Type 2 Diabetes Mellitus; Hs-CRP; Inflammation.References
Abebaw M, Messele A, Hailu M, Zewdu F. (2016). Adherence and Associated Factors Towards Antidiabetic Medication Among Type II Diabetic Patients on Follow-Up at University of Gondar Hospital, Northwest Ethiopia. Advances in Nursing. 2016;2016:1–7. https://doi.org/10.1155/2016/8579157
Almubarak, A., Nahadi, N., Yuliani, G., Talib, C. A., & Arini, D. N. (2024). Steinbuch’s epistemological model and the reality of particles: A philosophical perspective for chemistry education. Indonesian Journal on Learning and Advanced Education (IJOLAE), 7(1), 37-51. https://doi.org/10.23917/ijolae.v7i1.23911
Akrom A., Sari O.M., Urbayatun S. and Saputri Z. (2019) Analisis Determinan Faktor-Faktor yang Berhubungan dengan Kepatuhan Minum Obat Pasien Diabetes Tipe 2 di Pelayanan Kesehatan Primer. Jurnal Sains Farmasi & Klinis, 6 (1), 54–62. https://doi.org/10.25077/jsfk.6.1.5462.2019
Hardianto, D. 2021. Telaah Komprehensif Diabetes Melitus: Klasifikasi, Gejala, Diagnosis, Pencegahan, Dan Pengobatan: A Comprehensive Review of Diabetes Mellitus: Classification, Symptoms, Diagnosis, Prevention, and Treatment. Jurnal Bioteknologi & Biosains Indonesia (JBBI), 7(2), 304–317. https://doi.org/10.29122/jbbi.v7i2.4209
Hayes, A. J., Leal, J., Gray, A. M., Holman, R. R., & Clarke, P. M. (2013). UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82. Diabetologia, 56(9), 1925–1933. https://doi.org/10.1007/s00125-013-2940-y
Jilao, M. (2017). Tingkat Kepatuhan Penggunaan Obat Antidiabetes Oral pada Pasien Diabetes Melitus di Puskesmas Koh-Libong Thailand. Skripsi. Malang: UIN Maulana Malik Ibrahim.
Kamath, D., Xavier, D., Sigamani, A., & Pais, P. (2015). High sensitivity C-reactive protein (hsCRP) & cardiovascular disease: An Indian perspective. Indian Journal of Medical Research, 142(3), 261. https://doi.org/10.4103/0971-5916.166582
Kapero, F., Mahtuti, E., & Rahmawati, P. (2023). Description Of C-Reactive Protein (CRP) In Patients With Type 2 Diabetes Mellitus At Mulyorejo Health Center In Malang City. Jurnal Analis Medika Biosains (JAMBS), 10(2). https://doi.org/10.32807/jambs.v10i2.320
Kumar, A., Sharma, S., & Sinha, S. (2013). Effect of metformin therapy on high-sensitivity C-reactive protein levels in patients with type 2 diabetes mellitus. Journal of Clinical and Diagnostic Research, 7(12), 3020–3023.
Laliberte F, Bookhart BK, Nelson WW, Lefebvre P, Schein JR, Rondeau-Leclaire J, et al. (2013). Impact of Once-Daily Versus Twice-Daily Dosing Frequency on Adherence to Chronic Medications Among Patients with Venous Thromboembolism. The Patient - Patient-Centered Outcomes Research. 6(3):213–24. https://doi.org/10.1007/s40271-013-0020-5
Lee, J., Yun, J.-S., & Ko, S.-H. (2022). Advanced Glycation End Products and Their Effect on Vascular Complications in Type 2 Diabetes Mellitus. Nutrients, 14(15), 3086. https://doi.org/10.3390/nu14153086
Magliano, D. J., Zimmet, P., & Shaw, J. E. (2015). Classification of diabetes mellitus and other categories of glucose intolerance. In R. A. DeFronzo, E. Ferrannini, P. Zimmet, & K. G. M. M. Alberti (Eds.), International Textbook of Diabetes Mellitus (1st ed., pp. 1–16). https://doi.org/10.2337/diab.28.12.1039
Maung WYM, Tiraphat S, Puckpinyo A. 2017. Factors Associated With Medication Adherence Among Type 2 Diabetes Patients in A Private Clinic in Yangon, Myanmar. J of Public Health and Development. 15(1):18.
Nanda, O. D., Wiryanto, B., & Triyono, E. A. 2018. Hubungan Kepatuhan Minum Obat Anti Diabetik dengan Regulasi Kadar Gula Darah pada Pasien Perempuan Diabetes Mellitus. Amerta Nutrition, 2(4), 340. https://doi.org/10.20473/amnt.v2i4.2018.340-348
Notoatmodjo, S. (2014). Promosi Kesehatan dan Perilaku Kesehatan. Jakarta: Rineka Cipta.
Pramudyatama, I. W., Ichsan, B., & Noviyanti, R. D. (2024). Pengaruh antara Usia, Pengetahuan, dan Tingkat Pendidikan terhadap Kepatuhan Minum Obat Pasien Diabetes Melitus. Jurnal Keilmuan dan Keislaman, 152–159. https://doi.org/10.23917/jkk.v4i1.365
Purwandari, C. A. A., Wirjatmadi, B., & Mahmudiono, T. 2022. Faktor Risiko Terjadinya Komplikasi Kronis Diabetes Melitus Tipe 2 pada Pra Lansia. Amerta Nutrition, 6(3), 262–271. https://doi.org/10.20473/amnt.v6i3.2022.262-271
Rasdiana N, Martodiharjo S, Andayani, Hakim L. 2016. The Description of Medication Adherence for Patients of Diabetes Mellitus Type 2 in Public Health Center Yogyakarta. Indonesian J of Clinical Pharmacy. 5(4):249–57. https://doi.org/10.15416/ijcp.2016.5.4.249
Sa’dyah, N. A. C., Sabiti, F. B., & Susilo, S. T. 2021. Kepatuhan Pengobatan Terhadap Indeks Glikemik Kontrol Pada Pasien Diabetes Melitus Tipe II di Rumah Sakit Islam Sultan Agung Semarang. JPSCR: Journal of Pharmaceutical Science and Clinical Research, 6(3), 287. https://doi.org/10.20961/jpscr.v6i3.51930
Saisho, Y. 2015. Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect. Endocrine, Metabolic & Immune Disorders-Drug Targets, 15(3), 196–205. https://doi.org/10.2174/1871530315666150316124019
Salam MA, Siddiqui AF. 2017. Socio-Demographic Determinants of Compliance Among Type 2 Diabetic Patients in Abha, Saudi Arabia. J of Clinical and Diagnostic Research. 7(12):2810–3. https://doi.org/10.7860/JCDR/2013/6986.3708
Srikartika, V.M., Cahya, A. D., & Hardiati, R. S. W. (2016). Analisis Faktor Yang Mempengaruhi Kepatuhan Penggunaan Obat Pasien Diabetes Melitus Tipe 2. Jurnal Manajemen dan Pelayanan Farmasi.
Stanimirovic, J., Radovanovic, J., Banjac, K., Obradovic, M., Essack, M., Zafirovic, S., Gluvic, Z., Gojobori, T., & Isenovic, E. R. 2022. Role of C-Reactive Protein in Diabetic Inflammation. Mediators of Inflammation, 2022, 1–15. https://doi.org/10.1155/2022/3706508
Mas Ulfa, N., & Darmawan, R. (2021). Analysis Of The Effect Of Age On Medication Adherence With Oral Antidiabetes And Oral Antihypertension Drugs Using Pill Count Method: Analisis Pengaruh Usia terhadap Kepatuhan Minum Obat Oral Antidiabetes dan Oral Antihipertensi Menggunakan Metode Pill Count. Journal of Pharmacy and Science, 6(2), 63–68. https://doi.org/10.53342/pharmasci.v6i2.216
Wathani IHN, Purba MB, Helmyati S. Kepatuhan Minum Obat Hipoglikemik Oral Dan Indeks Massa Tubuh Terhadap Kadar Gula Darah Pada Pasien Diabetes Melitus Tipe 2. Jurnal Gizi Klinik Indonesia, Vol. 21, No. 2, 78-86. https://doi.org/10.22146/ijcn.91474
WHO. 2019. Classification of Diabetes Mellitus. Switzerland: World Health Organization.
Wikan, E., Rahmawati, F., & Wahab, I. A. (2021). Kepatuhan Penggunaan Obat pada Komunitas Pasien Lanjut Usia Dengan Penyakit Kronis di Kecamatan Muntilan Jawa Tengah. Majalah Farmaseutik, 17(1), 54. https://doi.org/10.22146/farmaseutik.v17i1.49088
License
Copyright (c) 2025 Intan Nur Ramadhani, Hari Saktiningsih Sakti
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
